Use of Misoprostol in First and Second Trimester Abortion
- 1 September 1999
- journal article
- review article
- Published by Wolters Kluwer Health in Obstetrical & Gynecological Survey
- Vol. 54 (9) , 592-600
- https://doi.org/10.1097/00006254-199909000-00024
Abstract
The use of misoprostol in medical termination of first and second term pregnancies and cervical priming in surgically induced termination of pregnancies has been studied extensively. A survey is given on the available literature (MEDLINE to May 1998) on the usage as a single medication or in combination with mifepristone or methotrexate. A review is given on literature concerning side effects and complications. Misoprostol is a most promising, cheap, and effective agent, which does not need cool storage like other prostaglandins. The use of misoprostol as an abortifacient has, however, not been supported by the manufacturer. This leads to the situation (similar to mifepristone/RU 486) that it is used and researched, but probably will not be officially approved for this specific indication.Keywords
This publication has 52 references indexed in Scilit:
- A randomised comparison of oral and vaginal misoprostol for cervical priming before suction termination of pregnancyBJOG: An International Journal of Obstetrics and Gynaecology, 1996
- Effect of vaginal misoprostol application for cervical softening in pregnancy interruption before ten weeks of gestationActa Obstetricia et Gynecologica Scandinavica, 1996
- Oral misoprostol versus vaginal gemeprost for cervical dilatation prior to vacuum aspiration in women in the sixth to twelfth week of gestationContraception, 1995
- Pregnancy: Oral misoprostol versus placebo for cervical dilatation before vacuum aspiration in first trimester pregnancyHuman Reproduction, 1995
- Is misoprostol the drug of choice for induced cervical ripening in early pregnancy termination?Acta Obstetricia et Gynecologica Scandinavica, 1995
- Cervical priming with prostaglandin E1 analogues, misoprostol and gemeprostThe Lancet, 1994
- What do women want during medical abortion?Contraception, 1992
- Wirkung des PGE1-Methylanalogons Misoprostol auf den schwangeren Uterus im ersten TrimesterGeburtshilfe und Frauenheilkunde, 1987
- MEASURES TO PREVENT CERVICAL INJURY DURING SUCTION CURETTAGE ABORTIONThe Lancet, 1983
- Complications from Legally-Induced AbortionObstetrical & Gynecological Survey, 1979